UK markets close in 2 hours 31 minutes

Artelo Biosciences, Inc. (ARTLW)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.0235+0.0073 (+45.06%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.20
52-week change 3N/A
S&P500 52-week change 321.23%
52-week high 30.0235
52-week low 30.0113
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 52.33M
Implied shares outstanding 6N/A
Float 83.2M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends N/A
Most-recent quarter (mrq)N/A

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-37.09%
Return on equity (ttm)-59.63%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-9.29M
Diluted EPS (ttm)-1.4290
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)10.43M
Total cash per share (mrq)3.23
Total debt (mrq)23k
Total debt/equity (mrq)0.20%
Current ratio (mrq)8.51
Book value per share (mrq)-0.35

Cash flow statement

Operating cash flow (ttm)-8.21M
Levered free cash flow (ttm)-4.64M